deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01934829

Urea Cream Treatment Sorafenib-Associated HSFR in HCC

Randomized Controlled Phase II Study of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma

Sponsor: Chinese Anti-Cancer Association

Conditions Hepatocellular Carcinoma
Interventions urea-based cream
Updated 4 times since 2017 Last updated: Aug 30, 2013 Started: Jul 31, 2009 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hepatocellular Carcinoma and is currently completed. Chinese Anti-Cancer Association leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE2

    First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese Anti-Cancer Association
Data source: Chinese Anti-Cancer Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations